Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A comprehensive review of monoamine oxidase inhibitors as Anti-Alzheimer’s disease agents: A review
Shoaib Manzoor, Nasimul Hoda
European Journal of Medicinal Chemistry (2020) Vol. 206, pp. 112787-112787
Closed Access | Times Cited: 178

Showing 1-25 of 178 citing articles:

Activity-based NIR fluorescent probes based on the versatile hemicyanine scaffold: design strategy, biomedical applications, and outlook
Haidong Li, Heejeong Kim, Feng Xu, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 5, pp. 1795-1835
Closed Access | Times Cited: 326
Alzheimer’s disease and its treatment by different approaches: A review
Sukriti Srivastava, Razi Ahmad, Sunil Kumar Khare
European Journal of Medicinal Chemistry (2021) Vol. 216, pp. 113320-113320
Closed Access | Times Cited: 324
Reactive oxygen species in biological systems: Pathways, associated diseases, and potential inhibitors—A review
Abdur Rauf, Anees Ahmed Khalil, Samir Awadallah, et al.
Food Science & Nutrition (2023) Vol. 12, Iss. 2, pp. 675-693
Open Access | Times Cited: 46
A critical review on recent trends on pharmacological applications of pyrazolone endowed derivatives
Ghulam Mustafa, Muhammad Zia‐ur‐Rehman, Sajjad Hussain Sumrra, et al.
Journal of Molecular Structure (2022) Vol. 1262, pp. 133044-133044
Closed Access | Times Cited: 56
Monoamine oxidase inhibitors: A concise review with special emphasis on structure activity relationship studies
Bhawna Verma, Ashwani Kumar, Meenakshi Bhatia, et al.
European Journal of Medicinal Chemistry (2022) Vol. 242, pp. 114655-114655
Closed Access | Times Cited: 37
Development of Isopropyl-Tailed Chalcones as a New Class of Selective MAO-B Inhibitors for the Treatment of Parkinson’s Disorder
Sunil Kumar, Jong‐Min Oh, Mohamed A. Abdelgawad, et al.
ACS Omega (2023) Vol. 8, Iss. 7, pp. 6908-6917
Open Access | Times Cited: 26
8-Hydroxyquinolylnitrones as multifunctional ligands for the therapy of neurodegenerative diseases
Damijan Knez, Daniel Diez‐Iriepa, Mourad Chioua, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 5, pp. 2152-2175
Open Access | Times Cited: 24
Photobiomodulation in Alzheimer’s Disease—A Complementary Method to State-of-the-Art Pharmaceutical Formulations and Nanomedicine?
Laura Marinela Ailioaie, Constantin Ailioaie, Gerhard Litscher
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 916-916
Open Access | Times Cited: 22
Recent advancement in understanding of Alzheimer's disease: Risk factors, subtypes, and drug targets and potential therapeutics
Sneh Prabha, Mohd Sajad, Gulam Mustafa Hasan, et al.
Ageing Research Reviews (2024) Vol. 101, pp. 102476-102476
Closed Access | Times Cited: 10
Quinoline–sulfonamides as a multi-targeting neurotherapeutic for cognitive decline:in vitro,in silicostudies and ADME evaluation of monoamine oxidases and cholinesterases inhibitors
Saquib Jalil, Zahid Hussain, Syed Mobashir Ali Abid, et al.
RSC Advances (2024) Vol. 14, Iss. 13, pp. 8905-8920
Open Access | Times Cited: 7
Exploitation of the multitarget role of new ferulic and gallic acid derivatives in oxidative stress-related Alzheimer's disease therapies: design, synthesis and bioevaluation
Fahad Hussain, Ayesha Tahir, Muhammad Saeed Jan, et al.
RSC Advances (2024) Vol. 14, Iss. 15, pp. 10304-10321
Open Access | Times Cited: 7
Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer’s action: Design, synthesis, crystal structure and in-vitro biological evaluation
Shoaib Manzoor, Santosh Kumar Prajapati, Shreyasi Majumdar, et al.
European Journal of Medicinal Chemistry (2021) Vol. 215, pp. 113224-113224
Closed Access | Times Cited: 51
Small-Molecule Inhibitors of Reactive Oxygen Species Production
Elisa Sassetti, Mads H. Clausen, Luca Laraia
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 9, pp. 5252-5275
Open Access | Times Cited: 51
Monoamine Oxidase (MAO) as a Potential Target for Anticancer Drug Design and Development
Reem Aljanabi, Lina Alsous, Dima A. Sabbah, et al.
Molecules (2021) Vol. 26, Iss. 19, pp. 6019-6019
Open Access | Times Cited: 51
Effect-directed analysis in food by thin-layer chromatography assays
Ignacio Cabezudo, Mario O. Salazar, I. Ayelen Ramallo, et al.
Food Chemistry (2022) Vol. 390, pp. 132937-132937
Closed Access | Times Cited: 33
Recent advancements in chromone as a privileged scaffold towards the development of small molecules for neurodegenerative therapeutics
Hari Madhav, Ehtesham Jameel, Mohammad Rehan, et al.
RSC Medicinal Chemistry (2022) Vol. 13, Iss. 3, pp. 258-279
Open Access | Times Cited: 29
Evaluation of pyrimidine/pyrrolidine-sertraline based hybrids as multitarget anti-Alzheimer agents: In-vitro, in-vivo, and computational studies
Muhammad Aamir Javed, Muhammad Saeed Jan, Abdullah M. Shbeer, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114239-114239
Open Access | Times Cited: 17
Investigation on the positive chronotropic action of 6-nitrodopamine in the rat isolated atria
José Britto‐Júnior, Antonio Tiago Lima, Vivian Fuguhara, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 396, Iss. 6, pp. 1279-1290
Open Access | Times Cited: 16
Enhancing the Therapeutic Effect in Alzheimer's Disease Drugs: The role of Polypharmacology and Cholinesterase inhibitors
M. Margarida Martins, Paula S. Branco, Luı́sa M. Ferreira
ChemistrySelect (2023) Vol. 8, Iss. 10
Open Access | Times Cited: 16
Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors
Mariagrazia Rullo, Gabriella La Spada, Daniela Valeria Miniero, et al.
European Journal of Medicinal Chemistry (2023) Vol. 255, pp. 115352-115352
Closed Access | Times Cited: 15
Practical Three-Component Regioselective Synthesis of Drug-Like 3-Aryl(or heteroaryl)-5,6-dihydrobenzo[h]cinnolines as Potential Non-Covalent Multi-Targeting Inhibitors To Combat Neurodegenerative Diseases
Hossein Mousavi, Mehdi Rimaz, Behzad Zeynizadeh
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 9, pp. 1828-1881
Closed Access | Times Cited: 6
Recent Advances in Metal–Organic Frameworks as Oxidase Mimics: A Comprehensive Review on Rational Design and Modification for Enhanced Sensing Applications
Sameera Sh. Mohammed Ameen, Alaa Bedair, Mahmoud Hamed, et al.
ACS Applied Materials & Interfaces (2024)
Closed Access | Times Cited: 5
Design, synthesis, and neuroprotective activity of salidroside-based dual inhibitors of selective monoamine oxidase B and amyloid-β aggregation
Juan Zhang, Kongkai Zhu, Kaiming Wang, et al.
Medicinal Chemistry Research (2025)
Closed Access
Design, synthesis, molecular docking, DFT analysis, dynamics simulation and cytotoxicity evaluation of coumarin derivatives as acetylcholinesterase (AChE) inhibitors against alzheimer's disease
Shivangi Rai, Vishal Singh, Iqrar Ahmad, et al.
Journal of Molecular Structure (2025), pp. 141436-141436
Closed Access
Synthesis and in-vitro cytotoxicity activity of 1,3,4-oxa-diazolbenzamide derivatives and inhibition of human MAO-A enzyme: A in-silico approaches
Mule Vijayalakshmi, R. Srinivasan
Analytical Chemistry Letters (2025), pp. 1-20
Closed Access
Page 1 - Next Page

Scroll to top